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S UMMA R Y
BACKGROUND : Data on spirometrically defined chron-
ic airflow limitation (CAL) are scarce in developing
countries.
OB J E C T I V E : To estimate the prevalence of spirometri-
cally defined CAL in Kashmir, North India.
METHODS : Using Burden of Obstructive Lung Disease
survey methods, we administered questionnaires to
randomly selected adults aged 740 years. Post-bron-
chodilator spirometry was performed to estimate the
prevalence of CAL and its relation to potential risk
factors.
R E SU LT S : Of 1100 participants initially recruited, 953
(86.9%) responded and 757 completed acceptable
spirometry and questionnaires. The prevalence of a
forced expiratory volume in 1 s/forced vital capacity
(FEV1/FVC) ratio less than the lower limit of normal
was 17.3% (4.5) in males and 14.8% (2.1) in females.
Risk factors for CAL included higher age, cooking with
wood and lower educational status. The prevalence of
current smoking was 61% in males and 22% in females;
most smoked hookahs. CAL was found equally in non-
smoking males and females, and was independently
associated with the use of the hookah, family history of
respiratory disease and poor education. A self-reported
doctor’s diagnosis of chronic obstructive pulmonary
disease was reported in 8.4/1000 (0.9% of females and
0.8% of males).
CONC LU S I ON : Spirometrically confirmed CAL is high-
ly prevalent in Indian Kashmir, and seems to be related
to the high prevalence of smoking, predominantly in the
form of hookah smoking.
K E Y WORD S : chronic airflow limitation; COPD; spi-
rometry; smoking; prevalence
CHRONIC OBSTRUCTIVE PULMONARY disease
(COPD), a disorder of chronic airflow limitation
(CAL) not reversed by bronchodilators (BDs), is now
the third most common cause of death worldwide.1
While most available information on COPD preva-
lence and morbidity comes from high-income coun-
tries, it is known that low- and middle-income
countries already shoulder much of the burden of
COPD mortality, with almost 90% of COPD deaths
occurring in these countries.1 While previous esti-
mates of prevalence have used self-reported doctor
diagnosis of COPD, the routine use of spirometry has
shown a wide gap between these estimates and the
actual burden as a result of underdiagnosis.2–7
Data from the Indian subcontinent are sparse and
based mostly on questionnaire surveys.8–12 Crude
estimates suggest that there are about 30 million
COPD patients in India,10 with prevalence rates
ranging from 2% to 22% in males and 12% to 19%
in females. In a recent countrywide questionnaire-
based survey in India, the prevalence of chronic
bronchitis was reported at 3.5% in adults aged 735
years (median prevalence 4.3% in males and 2.7% in
females).10 The only spirometry-based study from
India has reported a prevalence nearly two-fold
higher,11 suggesting that the true burden is much
higher than the reported burden.12
The Burden of Obstructive Lung Disease (BOLD)
study measures COPD prevalence in multiple coun-
tries based on standardised, quality controlled post-
BD spirometry.13 The present study was designed to
measure COPD prevalence in Kashmir, North India,
using the BOLD protocol.
METHODS
Study population
We surveyed a sex-stratified random sample of the
inhabitants of Hajan (Bandipora), Kashmir, India,
aged 740 years. Participants were selected from
information available from the Census department of
the state of Jammu and Kashmir (J&K). The survey
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was conducted among non-institutionalised residents
of the Bandipora District (population 210 017). Five
of the 115 regions that make up Bandipora District—
Dangerpora, Hajan, Madwan, Nesbal and Sumbal—
were selected, and random sampling of subregions
was used within each region to select the final sex-
stratified sample for the study. The population of
rural Kashmir is almost entirely Muslim, with
approximately 54% males.
We used the BOLD protocol to design and
complete the study using trained, certified person-
nel.14 All data collected were quality controlled on a
weekly/bi-weekly basis by the BOLD Coordinating
Centre in London, United Kingdom. Following an
initial house visit, potential participants were con-
tacted by phone or in person to schedule a visit to the
participant’s home. For all subjects contacted, an-
swers to a minimal data questionnaire were obtained.
Of the 1100 individuals whom we attempted to
contact, 3 were untraceable, 2 were unreachable and
12 had permanently moved from the area. Of the
remaining 1083 eligible participants, 953 (88%)
completed the full protocol and performed spirome-
try (responders). Of these, 757 performed acceptable
spirometry and constitute the sample for this analysis.
Study methodology
A team from the BOLD Coordinating Centre team
from London trained and certified the staff at Pune in
February 2010. Questionnaires were translated from
English into Kashmiri, then back-translated into
English by independent translators, according to the
International Quality of Life Assessment (IQOLA)
protocol. The back-translation was then compared
with the original English versions for accuracy and
piloted among 10 volunteers.
The questionnaires were administered to the study
participants in their native language through face-to-
face interviews. Information was recorded for respi-
ratory symptoms, smoking, other risk factors for
COPD, health status, medication use, health care
utilisation, comorbidities, respiratory diagnoses, and
physical and mental quality of life (Short Form-12
questionnaire, Quality Metrics, Lincoln, RI, USA).15
The other risk factors for COPD considered here
include type of cooking fuel, the use of kangris (an
earthenware pot with live wood-charcoal cinders
carried inside a long robe called ‘phiran’ for warmth),
history of tuberculosis (TB), education and body mass
index (BMI).
Spirometry was performed according to American
Thoracic Society (ATS) criteria,16 using the Easy-One
portable spirometer (ndd Medizintechnik; Zurich,
Switzerland), with the participant in a seated
position. Separate measurements were performed
before and at least 15 min after two puffs of
salbutamol (200 lg) administered via metered-dose
inhaler with a double valve volumatic spacer (Zero-
stat Spacer, Cipla Limited, Mumbai, India). Spirom-
etry data were transmitted electronically to the BOLD
Pulmonary Function Reading Centre in London,
where each spirogram was reviewed. A usable
spirometry had to meet ATS criteria for acceptability,
including having at least three attempts, two of which
were acceptable (i.e., free from artefact, sudden stops
and back-extrapolated volumes of .5.0% of forced
vital capacity [FVC]), with a difference between the
largest and second largest values of,200 ml for both
forced expiratory volume in 1 s (FEV1) and FVC.17
The spirometer was calibrated daily with a 3 l syringe,
and study staff were continuously monitored. When-
ever technicians’ quality scores dropped below a pre-
set level, they were required to stop testing and
undergo retraining and recertification.14
Definitions
The US National Health and Nutrition Examination
Study III (NHANES III) Caucasian reference equa-
tions18 were used to calculate the lower limit of
normal (LLN) and the per cent predicted values for
the primary analysis. The LLN is the value exceeded
by 95% of a ‘normal’ population, defined as
asymptomatic life-time non-smokers. We report
COPD stage 1 or higher defined by the lower limits
of normal (LLN) for post-BD FEV1/FVC based on the
NHANES Caucasian reference equations for age and
sex. Post-BD FEV1 ,80% of predicted was used for
COPD stage 2 or higher.
Doctor-diagnosed COPD was defined as self-
reported physician’s diagnosis of chronic bronchitis,
emphysema or COPD. The number of self-reported
pack-years of cigarettes smoked was defined as the
average number of cigarettes smoked per day divided
by 20 (i.e., packs per day) times the duration of
smoking in years. An equivalent value for pipefuls of
tobacco smoked from a hookah was taken from the
Smoking Pack Years Calculator.19 Education was
divided into none, primary and above primary
education.
Analysis
Prevalence estimates were calculated for the overall
Hajan population, as well as for subgroups defined by
sex and either age or ‘pack-years’ or equivalent of
smoking, using survey weights. These analyses were
performed using Stata 12 software (StataCorp,
College Station, TX, USA). Mean FEV1/FVC was
estimated for sex and 10-year age groups. The
proportion of participants with a low FEV1/FVC
ratio compared to the 95th centile of the values
reported by a NHANES ‘normal’ Caucasian popula-
tion was also calculated and reported for the same age
groups. To adjust for the expected decline in the ratio
with age the FEV1/FVC ratios were converted to
standard deviation (SD) scores based again on the
NHANES ‘normal’ Caucasian population. Because
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the sex distribution of participants aged740 years in
the database differed slightly from that for the
population (50.1% vs. 45.9% male), the data for
males and females were weighted so that the resulting
estimates of prevalence better represent the popula-
tion. Additional weighting class adjustments20 were
made to adjust for differential response rates for the
eight categories defined by sex and age (i.e., 40–49,
50–59, 60–69 and770 years).
The distributions of the main known risk factors
available in the data set were also set out by age group
and sex. These included family history of respiratory
disease, education level, cigarette smoking, water
pipe (hookah) smoking, use of kangris and a history
of TB.
Finally, the SD scores of the FEV1/FVC ratio were
regressed against the main risk factors. These models
included age, use of kangris, smoking of cigarettes
and hookahs and the length of exposure to each of
these in different combinations. All models were
adjusted for family history of respiratory disease,
educational level and exposure to passive smoking.
Analyses were weighted using Stata survey com-
mands. Regression diagnostics were performed to
check the assumption of normality of the error,
homogeneity of the variance and linearity between
standardised score and predictors in the model.
Ethics
The study was approved by the Institutional Ethical
Committee of the Sher-i-Kashmir Institute of Medical
Sciences, Srinagar, India.
RESULTS
Of 1097 participants approached, 41 provided no
information and the only data available are their age
and sex. A further 103 (9%) provided information on
smoking and diagnoses but did not provide further
information, leaving 953 responders. The baseline
characteristics of responders and non-responders are
presented in Appendix Table A.1.* Compared with
non-responders, responders were more likely to be
male (54% vs. 36%, P , 0.001), younger (54% vs.
42% aged ,50 years, P , 0.001) and never to have
smoked (46% vs. 57%, P , 0.001); however, there
was no significant difference in the prevalence of
doctor-diagnosed emphysema, COPD, asthma or
chronic bronchitis (2% vs. 3%, P ¼ 0.8) or of
reported comorbid conditions (27% vs. 25%, P ¼
0.7). Of the 953 responders, 757 (79%) provided
adequate post-BD spirometry. Those with adequate
spirometry results were similar to those without,
except that they were more likely to have ever smoked
cigarettes (13% vs. 6%), although they had a similar
overall exposure to tobacco of any type (55% vs.
51%) and kangris each day (8 h vs. 8.13 h).
Appendix Table A.2 shows selected characteristics
of the sample by sex. Women spent much longer
cooking with wood each day (3.7 h vs. 0.1 h). They
were also significantly more likely to have had no
education (88% vs. 65%) and twice as likely to be
overweight or obese (28% vs. 14%). History of
smoking (current or former) was higher among males
(80.4%) than females (33%). Hookah smoking was
more common among males than females at all ages.
In the youngest age group, smoking was less common
in males aged ,50 years and in females aged ,60
years; however, cigarette smoking was more common
among males aged ,50 years and was almost
unreported among females (Appendix Figure A).
Of the total population, 16.1% had a FEV1/FVC
ratio below the LLN (Appendix Table A.3). This
figure rose from 8.2% in those aged 40–49 years to
34.4% in those aged .69 years, and was higher in
males (17.3%) than females (14.8%). Those who in
addition had a FEV1,80% predicted for age, sex and
height (modified stage II) were almost as numerous:
14.2% overall, 15.6% in males, 12.7% in females,
7.2% in those aged ,50 years and 29.5% in those
aged 770 years. The decline with age from normal
values given by the NHANES standard measures was
greater than expected, and this is confirmed by the
increasing prevalence of a value below the LLN as age
progresses. The prevalence of obstruction, the pro-
portion who were below the LLN, was 11.2% in
males and 9.5% in females.
CAL prevalence was as high in never smokers as in
the general population, the group with the lowest
prevalence being those who had smoked less than 10
pack-years. Among never smokers, CAL prevalence
was marginally lower among females than among
males. The prevalence of a self-reported doctor’s
diagnosis of COPD was 8.4 per 1000, and very much
lower than the spirometrically diagnosed prevalence
of chronic airflow obstruction.
The main risk factors were also strongly associated
with age; these include length of exposure to cigarette
smoking, hookah smoking and use of kangris
(Appendix Table A.4). The main source of exposure
to tobacco was from hookahs, and these, unlike
cigarettes, are commonly used by females as well as
males. A reported family history of respiratory
disease was not uncommon, and was high in the
youngest age group. History of TB was rare. The
great majority of the population was underweight by
Western standards, and very few were overweight or
obese.
Appendix Table A.5 shows the regression coeffi-
cients for standardised deviation score of FEV1/FVC.
Visual checks of the diagnostic plots looked reason-
able and indicated a good fit of the model. The first
* The appendix is available in the online version of this article, at
http://www.ingentaconnect.com/content/iuatld/ijtld/2016/
00000020/000000010/art00025
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column (unadjusted model) gives the univariate
associations, which show significant negative associ-
ations with family history of respiratory disease, age,
use of kangris, use of hookahs and farming and
positive associations with higher education. Mutual
adjustment for family history, education, age and
passive smoke exposure (Model 1) shows that all
these variables have independent effects. Removing
age from the model, but adding years of hookah use
and years of kangri use (Model 2), shows significant
associations for both of these exposures. Adjusting
for age again (Model 3) shows no significant
association with age but removes the significance of
the effect of kangri use, although the coefficient
remains unchanged. The effect of hookah use
remained significant. BMI was not associated with
the outcome in the unadjusted comparison, and this
was true also for the final adjusted models. Exposure
to passive smoking was negatively, but not signifi-
cantly, associated with the FEV1/FVC ratio in the
unadjusted model. When the final model was
adjusted for passive smoking, most of the associations
were strengthened, but the association with passive
smoking was reversed and was of only borderline
significance.
Whichever model is examined, there are significant
independent associations with family history of
respiratory disease, education and hookah smoking.
Kangri use is only significant if age is left out of the
model, and if age and kangri use are included in the
model neither kangri use nor age are significantly
associated with the FEV1/FVC ratio. The adverse
association with passive smoking seen in the model
adjusted simply for age, family history and education
is reversed in the more fully adjusted models.
The association of the FEV1/FVC ratio with
selected risk factors may be expressed as both a
continuous measure of FEV1/FVC and as the preva-
lence of those with a ratio less than the LLN. Smoking
was not associated with a low FEV1/FVC ratio in this
study, although former smokers tended to have the
worst ratios. The highest prevalence of obstruction
was in the small number who smoked at least 20
pack-years, but as there were only 12 of these the
analysis has little power to show an effect. There was
a tendency for those exposed to passive smoke to be
at higher risk. Spending hours cooking with wood
and biomass was associated with worse lung func-
tion, although this was only clearly significant for the
analysis of the binary variable. Lack of education also
appeared to be a risk factor, although this was only
significant for the analysis of the continuous variable.
DISCUSSION
Our results show that about a sixth of the population
aged 740 years in Kashmir has Stage I or higher
CAL, but that only 0.73% report doctor-diagnosed
COPD. These figures show a much higher burden of
CAL in our population than in previous national
estimates,12 but a previous questionnaire and peak
flow meter-based survey reported a prevalence of
chronic bronchitis in Kashmir of 7.7%, with higher
prevalence among smokers and those living in poorly
ventilated houses.21 CAL prevalence in our popula-
tion was much higher than other comparable low-
income centres in India, such as Pune and Mumbai.11
The single most important cause of airflow
obstruction was smoking, and smoking prevalence
was high, particularly of traditional hookahs, among
the older population. Whereas the use of hookahs
was widespread among both males and females,
cigarette smoking was confined to younger males. We
reported earlier that hookah smoking confers a higher
risk of lung cancer compared to cigarette smoking,22
and the current study shows that it may be an
important contributory factor in causing CAL as
well. In Kashmiri hookahs, molasses is added to the
tobacco, with direct contact between the live charcoal
embers and the tobacco in the head of the hookah.
This leads to higher temperatures than in other
shishas, where a metal foil separates the tobacco
from the burning charcoal. This unique feature may
subject the tobacco to greater pyrolysis and result in a
higher concentration of the products of tobacco
combustion and the burning wood charcoal. In
addition, the water in the body of the hookah may
not be changed for many days, which could lead to a
higher concentration of toxic products in the water
through which the smoke passes before inhalation.23
Kashmir is a moderate altitude area with severe
winters that confine people to their homes for
prolonged periods, with potentially higher exposure
to indoor air pollution due to a much greater use of
biomass fuel for heating and cooking. Kangris are
used for personal heating, providing very close
exposure to biomass fuel. Although it has been
argued that the use of indoor biomass fuels may
explain the high mortality rates from COPD in low-
income countries,24 we were unable to show a
convincing association between use of biomass and
airflow obstruction. Although this could be due to
universally high exposure, the lack of a measurable
effect is consistent with the results from an earlier
BOLD analysis,25 and from the Kedourie cohort.26
We did find suggestive evidence of an association with
greater exposure to kangris.
Exposure to passive smoking was negatively, but
not significantly, associated with obstruction before
adjustment for potential confounders. However,
when our final model was adjusted for passive
smoking, most associations were strengthened, but
the association with passive smoking was reversed
and was only of borderline significance. All these
exposures were too highly correlated with age and
with each other to allow us to distinguish the
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individual effects of each. In so far as these could be
disentangled, the most likely cause of the high
prevalence of obstruction was the extensive use of
hookah smoking.
We found a significant association of family history
of respiratory disease and poor education with high
CAL prevalence. Health outcomes consistently show
significant social gradients, and improving access to
education is regarded as one of the major social
interventions for addressing the huge burden of non-
communicable diseases (NCDs).27 While our findings
lend additional support to this view, a clear explana-
tion for the association is still lacking.
Kashmiris are also ethnically and phenotypically
different from the rest of the Indian population, and a
preliminary principal component analysis has sug-
gested a genetic relation to Europeans.28
The highest burden of CAL in our study was in
males aged 770 years and females aged 760 years.
India has witnessed a change in the average life span,
from an average of 37 years in 1950 to about 69 years
in 2010;29 further ageing of the population is going to
be an important determinant of the future prevalence
of the disease in the country. Developing countries are
experiencing an ever-increasing burden of NCDs. In
India, NCDs account for 53% of all deaths and 44%
of disability-adjusted life-years (DALYs), and are
projected to constitute 67% of total deaths by
2030.30 Of these, chronic respiratory disease ac-
counts for 7% of deaths and 3% of DALYs lost.31
The number of COPD patients is projected to be 22
million by 2016, many requiring hospitalisation and
burdening the already resource-constrained health
care system.32 India contributes significantly and
increasingly to global COPD mortality.33
We used the LLN of the FEV1/FVC ratio for
defining CAL against the fixed ratio recommended by
the Global Initiative for Chronic Obstructive Lung
Disease (GOLD), as the GOLD criterion does not
take into account the decline in lung function with
age,34 and is less able to identify related abnormal-
ities.35 As there is little evidence for any substantial
difference in the FEV1/FVC ratio between ethnic
groups,13,33,36,37 we have used the equations from the
NHANES study to estimate the LLN and the
percentage predicted. The adequacy of this single
standard is confirmed by an analysis substituting
normal values generated from the Kashmir data,
which gave very similar answers.
A striking finding in this study was the wide gap
between the estimates of doctor-diagnosed COPD
and that of actual prevalence. Increased awareness
among medical personnel about the need for the
increased use of spirometry in diagnosing CAL is thus
required. This should be undertaken in tandem with
awareness activities to disseminate the preventable
nature of CAL. The use of BDs or inhaled corticoste-
roids was also found to be low, in line with other low-
and middle-income countries. The estimated rate of
use of inhaled BDs/inhaled corticosteroids was 2.4%,
whereas that of influenza vaccine was nil,38 due to a
number of possible factors, including local beliefs and
misconceptions regarding the use of inhalation
devices.39
Our study was limited by the fact that the largely
rural setting of the study area may not have been
representative of the whole country, where occupa-
tions, patterns of biomass fuel use or other sociocul-
tural practices differ. However, the strengths of the
study are its robust design, the objective evidence of
airflow limitation and the homogeneity of the
population studied. As participants with acceptable
spirometry results constituted ,80% of those re-
cruited, there is some possibility of bias. However,
this is likely to be small, as this was an association
study with a response rate of around 70%, in which
the major confounders (age, sex and smoking) had
been adjusted for and weighting had been used to
take into account the age-sex distribution of the
original population.
In conclusion, CAL is highly prevalent in Kashmir,
and similar studies need to be undertaken across the
country to obtain an accurate assessment of the
COPD burden in the ever-increasing and ageing
population of the second most populous country in
the world. Interventions aimed at prevention and
cessation of smoking, including the use of hookahs, is
essential to prevent the impending explosion of
tobacco-related diseases such as COPD, cancer and
cardiovascular disease. The use of biomass fuels, and
in particular the use of kangris, and their possible role
in causing chronic lung disease requires further
evaluation.
Acknowledgements
The study was funded by the Sher-i-Kashmir Institute of Medical
Sciences, Srinagar, India. The co-ordination of this part of the
BOLD study was funded by the Wellcome Trust, London, UK
(grant 085790/2/08/2).
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Conflicts of interest: none declared.
References
1 Lozano R, Naghavi M, Foreman K, et al. Global and regional
mortality from 235 causes of death for 20 age groups in 1990
and 2010: a systematic analysis for the Global Burden of
Disease Study 2010. Lancet 2013; 380: 2095–2128.
2 Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive
lung disease and low lung function in adults in the United
States. Arch Intern Med 2000; 160: 1683–1689.
3 Fukuchi Y, NishimuraM, IchinoseM, et al. COPD in Japan: the
Nippon COPD Epidemiology study. Respirology 2004; 9: 458–
465.
4 Kim D S, Kim Y S, Chung K S, et al. Korean Academy of
Tuberculosis and Respiratory Diseases. Prevalence of chronic
obstructive pulmonary disease in Korea: a population-based
CAL in North India: the BOLD study 1403
spirometry survey. Am J Respir Crit Care Med 2005; 172: 842–
847.
5 Pen˜a V S, Miravitlles M, Gabriel R, et al. Geographic variations
in prevalence and underdiagnosis of COPD: results of the
IBERPOC Multicentre Epidemiological Study. Chest 2000;
118: 981–989.
6 Halbert R J, Isonaka S, George D, Iqbal A. Interpreting COPD
prevalence estimates: what is the true burden of disease? Chest
2003; 123: 1684–1692.
7 Halbert R J, Natoli J L, Gano A, Badamgarav E, Buist A S,
Mannino DM. Global burden of COPD: systematic review and
meta-analysis. Eur Respir J 2006; 28: 523–532.
8 Salve S, Agarwal A. India needs a national COPD prevention
and control program. J Assoc Physicians India 2012; 60 (Suppl):
5–7.
9 Jindal S K, Aggarwal A N, Gupta D. A review of population
studies from India to estimate national burden of chronic
obstructive pulmonary disease and its association with
smoking. Indian J Chest Dis Allied Sci 2001; 43: 139–146.
10 Jindal S K, Aggarwal A N, Gupta D, et al. Indian study on
epidemiology of asthma, respiratory symptoms and chronic
bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012;
16: 1270–1277.
11 Burney P, Jithoo A, Kato B, et al. Burden of Obstructive Lung
Disease (BOLD) Study. Chronic obstructive pulmonary disease
mortality and prevalence: the associations with smoking and
poverty—a BOLD analysis. Thorax 2014; 69: 465–473.
12 Koul P A. Chronic obstructive pulmonary disease: Indian
guidelines and beyond. Lung India 2013; 30: 175–177.
13 Buist A S, Vollmer W M, Sullivan S D, et al. The Burden of
Obstructive Lung Disease initiative (BOLD): rationale and
design. J COPD 2005; 2: 277–283.
14 Enright P, Vollmer W M, Lamprecht B, et al. Quality of
spirometry tests performed by 9893 adults in 14 countries: the
BOLD Study. Respir Med 2011; 105: 1507–1515.
15 Ware J Jr, KosinskiM, Keller S D. A 12-Item Short-FormHealth
Survey: construction of scales and preliminary tests of
reliability and validity. Med Care 1996; 34: 220–233.
16 American Thoracic Society Statement. Standardization of
spirometry, 1994 update. Am J Respir Crit Care Med 1995;
152: 1107–1136.
17 Hankinson J, Eschenbacher B, Townsend M, Stocks J, Quanjer
P. Use of forced vital capacity and forced expiratory volume in 1
second quality criteria for determining a valid test. Eur Respir J.
2015; 45: 1283–1292.
18 Hankinson J L, Odencrantz J R, Fedan K B. Spirometric
reference values from a sample of the general US population.
Am J Respir Crit Care Med 1999; 159: 179–187.
19 Masters N, Tutt C. Smoking pack year calculator 2007.
Hazlemere, UK: Smoking Pack Years, 2007–2013. http://
smokingpackyears.com/. Accessed June 2016.
20 Lohr S L. Sampling: design and analysis. Pacific Grove, CA,
USA: Duxbury Press Publishing Company, 1999: pp 268–269.
21 Qureshi K A. Domestic smoke pollution and prevalence of
chronic bronchitis/asthma in a rural area of Kashmir. Indian J
Chest Dis Allied Sci 1994: 362: 61–72.
22 Koul P A, Hajni M R, Sheikh M A, et al. Hookah smoking and
lung cancer in the Kashmir Valley of Indian subcontinent. Asian
Pac J Cancer Prev 2011; 12: 519–524.
23 Koul P A, Chaouachi K. Important clarifications about
peculiarities of hookah smoking and lung cancer in Kashmir.
Asian Pac J Cancer Prev 2011; 12: 2145–2146.
24 Salvi S, Barnes P. Chronic obstructive pulmonary disease in
non-smokers. Lancet 2009; 374: 733–743.
25 Hooper R, Burney P, Vollmer W, et al. Risk factors for COPD
spirometrically defined from the lower limit of normal in the
BOLD project. Eur Respir J 2012; 39: 1343–1353.
26 Smith M, Li L, Augustyn M, et al. Prevalence and correlates of
airflow obstruction in 317,000 never-smokers in China. Eur
Respir J 2014; 44: 66–77.
27 United Nations Development Programme. Addressing the
social determinants of non-communicable disease. New York,
NY, USA: UNDP, 2013. http://www.undp.org/content/dam/
undp/library/hivaids/English/Discussion_Paper_Addressing_
the_Social_Determinants_of_NCDs_UNDP_2013.pdf.
Accessed June 2016.
28 Reich D, Thangaraj K, Patterson N, Price A L, Singh L.
Reconstructing Indian population history. Nature 2009; 24;
461: 489–494.
29 International Institute for Population Sciences (IIPS), Harvard
School of Public Health, and RAND Corporation, USA.
Longitudinal ageing study in India (LASI-Pilot survey), 2010.
Noida, India: IIPS, 2010: p 25.
30 Mahal A, Karan A, Engelgau M. The economic implications of
non-communicable disease for India. Washington DC, USA:
The International Bank for Reconstruction and Development/
The World Bank, 2009: p xiv.
31 Reddy K S, Mohan S. Chronic diseases in India: burden and
implications. Swiss Re Center for Global Dialogue. Ru¨schlikon,
Switzerland: Swiss Re, 2014, http: //cgd.swissre.com/global_
dialogue/topics/Cardiovascular_risks_in_HGM/Chronic_
Diseases_in_India Burden_and_Implications.html. Accessed
June 2016.
32 Indian Council of Medical Research-Medical Research Council
Workshop. Building Indo-UK collaboration in chronic diseases.
New Delhi, India: ICMR, 2009: p 16.
33 Lopez A D, Shibuya K, Rao C, et al. Chronic obstructive airway
disease: current burden and future projections. Eur Respir J
2006; 27: 397–412.
34 Rossiter C E, Weill H. Ethnic differences in lung function:
evidence for proportional differences. Int J Epidemiol 1974; 3:
55–61.
35 Vaz Fragoso C A, McAvay G, Van Ness P H, et al. Phenotype of
spirometric impairment in and aging population. Am J Respir
Crit Care Med 2016; 193: 727–735.
36 Pauwels R A, Buist A S, Calverley P M A, Jenkins C R, Hurd S
S. The GOLD Scientific Committee: global strategy for
diagnosis, management, and prevention of chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2001; 163:
1256–1276.
37 Hooper R, Burney P. Cross-sectional relation of ethnicity to
ventilatory function in a West London population. Int J Tuberc
Lung Dis 2013; 17: 400–405.
38 Gnatiuc L, Buist A S, Kato B, et al. Gaps in using
bronchodilators, inhaled corticosteroids and influenza vaccine
among 23 high- and low-income sites. Int J Tuberc Lung Dis
2015; 19: 21–30.
39 Koul P A. Managing chronic diseases: combination of inhaler
treatment in India has shown good results. BMJ 2005; 330: 964.
1404 The International Journal of Tuberculosis and Lung Disease
APPENDIX
Table A.1 Comparison of responders and non-responders
Responders* Non-responders† P value‡ Responders§ Non-responders¶ P value‡
Age, years (n ¼ 953) (n ¼ 144) ,0.001 (n ¼ 757) (n ¼ 340) 0.002
40–49 515 (54) 60 (42) 423 (56) 147 (45)
50–59 215 (23) 23 (16) 158 (21) 77 (24)
60–69 147 (15) 34 (23) 118 (16) 58 (18)
770 76 (8) 27 (19) 58 (8) 44 (14)
Sex (n ¼ 953) (n ¼ 144) ,0.001 ,0.001
Male 510 (54) 52 (36) 414 (55) 142 (44)
Female 443 (46) 92 (64) 343 (45) 184 (56)
Smoking status# (n ¼ 953) (n ¼ 103) ,0.001 ,0.001
Current 445 (47) 1 (1) 357 (47) 88 (30)
Ex 70 (7) 43 (42) 59 (8) 54 (18)
Never 438 (46) 59 (57) 341 (45) 154 (52)
Doctor diagnosed asthma,
emphysema, CB or COPD (n ¼ 953) (n ¼ 103)
,0.001Yes 23 (2) 3 (3) 0.756 19 (3) 7 (2)
No 930 (98) 100 (97) 738 (97) 289 (98)
Other comorbid conditions (n ¼ 953) (n ¼ 103) 0.196
Yes 260 (27) 26 (25) 0.658 214 (28) 72 (24)
No 693 (73) 77 (75) 543 (72) 224 (76)
* Those who completed post-BD spirometry (regardless of QC scores) and the core questionnaire.
† Eligible individuals with missing core questionnaire and/or post-BD spirometry results, but for whom the tabulated variable was known.
‡ Two-sided P value based on Pearson v2 test.
§ Responders with acceptable spirometry results.
¶ Non-responders in Column 3 and responders with non-acceptable spirometry results.
# Smoking status by any tobacco smoking.
CB¼ chronic bronchitis; COPD¼ chronic obstructive pulmonary disease; BD¼ bronchodilator; QC¼ quality control.
Table A.2 Characteristics of the sample according to sex
Male
(n ¼ 510)
n (%)
Female
(n ¼ 443)
n (%) P value
Age, years, mean 6 SD 52 6 10.53 51.24 6 10.04 0.26
Height cm, mean 6 SD 165.64 6 6.65 154.02 6 6.82 ,0.001
FVC, l, mean 6 SD 3.75 6 0.74 2.66 6 0.03 ,0.001
FEV1/FVC, %, mean 6 SD 75.15 6 11.23 77.91 6 9.57 ,0.001
Predicted FEV1/FVC, %, mean 6 SD 77.42 6 2.16 79.94 6 2.19 ,0.001
Mean FEV1/FVC/predicted, mean 6 SD 0.970 6 0.13 0.974 6 0.11 0.63
Fuel use
Cooking with kerosene 195 (38.24) 161 (36.34) 0.55
Use of kangri, /h/day, mean 6 SD 8 6 1.68 8.13 6 1.08 0.16
Cooking with wood, /h/day, mean 6 SD 0.10 6 0.75 3.69 6 1.29 ,0.001
Passive smoking 312 (61.18) 308 (69.53) 0.01
History of TB 2 (0.39) 3 (0.68) 0.55
Doctor-diagnosed COPD* 4 (0.78) 4 (0.90) 0.53
Education ,0.001
None 329 (64.76) 391 (88.46)
Middle school 82 (16.14) 30 (6.79)
High school 77 (15.16) 15 (3.39)
Higher education 20 (3.94) 6 (1.36)
BMI, kg/m2 ,0.001
Underweight (,18.5) 57 (11.18) 43 (9.73)
Normal (18.5–25) 382 (74.90) 275 (62.22)
Overweight (25–30) 66 (12.94) 89 (20.14)
Obese (.30) 5 (0.98) 35 (7.92)
Smoking (any) ,0.001
Never 138 (25) 359 (71)
Ex 76 (14) 37 (7)
Current 337 (61) 109 (22)
/10 pack years, mean 6 SD 0.21 6 0.59 0.002 6 0.04 ,0.001
* Includes chronic bronchitis or emphysema.
SD¼ standard deviation; FVC¼ forced vital capacity; FEV1¼ forced expiratory volume in 1 s; TB¼ tuberculosis; COPD¼
chronic obstructive pulmonary disease; BMI¼ body mass index.
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Table A.3 Distribution of FEV1/FVC ratio and airway obstruction by age and sex
Sex n
FEV1/FVC
Mean 6 SD
FEV1/FVC , LLN
% (SE)
FEV1/FVC , 0.70
% (SE)
Males
40–49 230 79.42 6 8.06 8.2 (3.0) 10.4 (3.1)
50–59 84 73.55 6 10.33 22.4 (6.6) 29.5 (7.0)
60–69 67 68.41 6 12.33 28.2 (5.8) 41.7 (7.5)
770 33 63.12 6 13.81 45.9 (9.0) 66.6 (2.3)
Total 414 75.14 6 11.21 17.3 (4.5) 23.7 (5.5)
Females
40–49 193 81.29 6 7.40 8.2 (3.0) 5.5 (1.9)
50–59 74 74.29 6 11.55 20.3 (4.8) 20.3 (4.8)
60–69 51 73.71 6 8.21 29.1 (8.7) 30.9 (8.8)
770 25 71.16 6 10.41 21.8 (6.9) 33.8 (12.6)
Total 343 77.92 6 9.54 14.8 (2.1) 14.5 (2.1)
Population
40–49 423 80.27 6 7.82 8.2 (1.8) 8.0 (1.7)
50–59 158 73.89 6 10.89 21.4 (4.1) 25.0 (4.2)
60–69 118 70.70 6 11.03 28.6 (5.1) 36.8 (5.9)
770 58 66.59 6 12.90 34.4 (6.4) 51.1 (7.5)
Total 757 76.40 6 10.60 16.1 (2.5) 19.3 (2.9)
FVC¼ forced vital capacity; FEV1¼ forced expiratory volume in 1 s; SD¼standard deviation; LLN¼ lower limit of normal;
SE¼ standard error.
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Table A.4 Distribution of principal exposures by age and sex
Exposure
Males Females
40–59 years
(n ¼ 383)
%
760 years
(n ¼ 127)
%
40–59 years
(n ¼ 347)
%
760 years
(n ¼ 96)
%
Tobacco exposure
Any tobacco smoking
Ever 72 86 23 43
Current 65 67 19 7
Pack years, mean 6 SD 195 (169) 415 (290) 165 (150) 317 (217)
Cigarette smoking
Ever 26 6 0.1 *
Current 22 3 0.1 *
Pack years, mean 6 SD 9.45 (7.48) 23.20 (18.16) 8.4 *
Hookah smoking
Ever 59 84 23 43
Current 53 66 19 37
Pack years, mean 6 SD 232 (161) 420 (289) 165 (150) 317 (217)
Exposure to current passive smoking 73 27 77 23
Exposure to dust (farming)
Ever 61 39 63 37
Exposure, years, mean 6 SD 27.26 (9.61) 46.43 (9.85) 25.49 (7.07) 40 (9.32)
Exposure to indoor air pollution
Wood for cooking
Ever 75 25 78 22
Exposure, years, mean 6 SD 40.50 (6.09) 60.97 (5.71) 39.75 (7.09) 58.44 (6.94)
Wood for heating
Ever 75 25 78 22
Exposure, years, mean 6 SD 40.00 (6.95) 60.57 (6.29) 39.15 (7.93) 58.35 (6.87)
Use of kangri
Ever 75 25 78 22
Exposure, years, mean 6 SD 37.09 (6.03) 57.51 (5.21) 36.87 (5.94) 56.77 (6.41)
Education
None 57 87 86 98
Primary 20 5 8 1
Higher 22 9 6 1
Body mass index, kg/m2
Underweight (,18.5) 75 75 63 58
Normal (18.5–25) 10 14 9 13
Overweight (25–30) 14 10 21 19
Obese (.30) 1 1 7 10
Family history of respiratory diseases
Yes 67 33 91 10
History of TB
Positive 0.3 0.8 0.9 0
*No observation.
SD¼ standard deviation; TB¼ tuberculosis.
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Figure A Prevalence of male cigarette smoking by age group.
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R E S U M E
CON T E X T E : Les donne´es relatives a` la limitation
chronique du flux ae´rien (CAL) de´finies par
spirome´trie sont rares dans les pays en de´veloppement.
OB J E C T I F : Estimer la pre´valence de la CAL de´finie par
spirome´trie au Cachemire dans le Nord de l’Inde.
M E´ THODE S : Graˆce aux me´thodes d’enqueˆte Burden of
Obstructive Lung Disease, nous avons soumis des
questionnaires a` des adultes aˆge´s de 740 ans choisis
au hasard. La spirome´trie apre`s bronchodilatateurs a e´te´
re´alise´e afin d’estimer la pre´valence de la CAL et sa
relation a` des facteurs de risque potentiels.
R E´ S U LTAT S : Sur 1100 participants initialement
recrute´s, 953 (86,9%) ont re´pondu, 757 ont eu une
spirome´trie acceptable et ont rempli les questionnaires.
La pre´valence d’un ratio de volume expiratoire
maximum seconde/capacite´ vitale force´e infe´rieur a` la
limite basse de la normale a e´te´ de 17,3% (4,5) chez les
hommes et de 14,8% (2,1) chez les femmes. Les facteurs
de risque de CAL incluaient un aˆge plus avance´, le fait de
cuisiner avec du bois et un niveau d’instruction plus bas.
La pre´valence du tabagisme a e´te´ de 61% chez les
hommes et de 22% chez les femmes ; la majorite´ fumait
des hookahs (narguile´). Une CAL a e´te´ de´couverte aussi
fre´quemment chez les hommes et les femmes non-
fumeurs et a e´te´ associe´e inde´pendamment a` l’usage du
hookah, a` des ante´ce´dents familiaux de maladie
respiratoire et a` un faible niveau d’instruction. Parmi
ces patients, 8,4/1000 personnes (0,9% des femmes et
0,78% des hommes) ont de´clare´ avoir eu un diagnostic
me´dical de bronchopneumopathie chronique
obstructive.
CONC LU S I ON : La CAL confirme´e par spirome´trie est
tre`s fre´quente dans le Cachemire Indien et semble lie´e a`
la pre´valence e´leve´e du tabagisme, qui consiste surtout
en usage du hookah.
R E S UM E N
MARCO D E R E F E R EN C I A: Los paı´ses en desarrollo
cuentan con escasos datos sobre la limitacio´n cro´nica
al flujo en las vı´as ae´reas (CAL) medida por me´todos
espirome´tricos.
OB J E T I VO: Calcular la prevalencia de CAL medida por
me´todos espirome´tricos en Kashmir, al norte de la India.
METODOS: Se aplicaron los me´todos de encuesta del
estudio Burden of Obstructive Lung Disease y se
suministraron cuestionarios a adultos de edad de 740
an˜os, escogidos de manera aleatoria. Se practico´ una
espirometrı´a tras la administracio´n de
broncodilatadores, con el fin de estimar la prevalencia
de CAL y evaluar su relacio´n con los posibles factores de
riesgo.
R E SU LTADOS: De los 1100 participantes solicitados
inicialmente, 953 respondieron (86,9%) y 757
completaron una espirometrı´a aceptable y
respondieron al cuestionario. La prevalencia de un
cociente del volumen espiratorio ma´ximo en el primer
segundo y la capacidad vital forzada ma´s bajo que el
lı´mite inferior normal fue 17,3% (4,5) en los hombres y
14,8% (2,1) en las mujeres. Los factores de riesgo de una
CAL fueron la edad mayor, la utilizacio´n de madera en la
coccio´n de los alimentos y un bajo grado de instruccio´n.
La prevalencia de tabaquismo actual fue 61% en los
hombres y 22% en las mujeres; la mayorı´a de las
personas utilizaba narguiles. La presencia de CAL fue
equivalente en los hombres y las mujeres no fumadores;
los factores que se asociaron de manera independiente
con la CAL fueron el uso de narguile, un antecedente
familiar de enfermedad respiratoria y el bajo grado de
instruccio´n. De cada 1000 personas, 8,4 refirieron un
diagno´stico de enfermedad pulmonar cro´nica
obstructiva establecido por un me´dico (0,9% en las
mujeres y 0,78% en los hombres).
CONC LU S I ON: La CAL, confirmada por espirometrı´a,
es muy frecuente en la regio´n Cachemira de la India y
parece relacionada con la alta prevalencia de
tabaquismo, cuya forma predominante es la utilizacio´n
del narguile.
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